+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling



TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling



American Journal of Physiology. Heart and Circulatory Physiology 282(4): H1288-H1295



The cytokine tumor necrosis factor (TNF)-alpha has been causally linked to left ventricular (LV) remodeling, but the molecular basis for this effect is unknown. Matrix metalloproteinases (MMPs) have been implicated in cardiac remodeling and can be regulated by TNF-alpha. This study tested the central hypothesis that administration of a TNF-alpha blocking protein would prevent the induction of MMPs and alter the course of myocardial remodeling in developing LV failure. Adult dogs were randomly assigned to the following groups: 1) chronic pacing (250 beats/min, 28 days, n = 12), 2) chronic pacing with concomitant administration of a TNF-alpha blocking protein (TNF block) using a soluble p75 TNF receptor fusion protein (TNFR:Fc; administered at 0.5 mg/kg twice a week subcutaneously, n = 7), and 3) normal controls (n = 10). LV end-diastolic volume increased from control with chronic pacing (83 +/- 12 vs. 118 +/- 10 ml, P < 0.05) and was reduced with TNF block (97 +/- 9 ml, P < 0.05). MMP zymographic levels (92 kDa, pixels) increased from control with chronic pacing (36,848 +/- 9,593 vs. 87,247 +/- 12,912, P < 0.05) and was normalized by TNF block. Myocardial MMP-9 and MMP-13 levels by immunoblot increased with chronic pacing relative to controls (130 +/- 10% and 118 +/- 6%, P < 0.05) and was normalized by TNF block. These results provide evidence to suggest that TNF-alpha contributes to the myocardial remodeling process in evolving heart failure through the local induction of specific MMPs.

(PDF emailed within 0-6 h: $19.90)

Accession: 011450248

Download citation: RISBibTeXText

PMID: 11893563

DOI: 10.1152/ajpheart.00526.2001


Related references

TNF-a and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling. American Journal of Physiology 282(4): 288-H1295, 2002

Regulation of matrix metalloproteinases is at the heart of myocardial remodeling. American Journal of Physiology. Heart and Circulatory Physiology 295(4): H1375-6, 2008

Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling. Zhonghua Nei Ke Za Zhi 43(11): 828-831, 2005

Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure. Zhonghua Yi Xue Za Zhi 86(24): 1693-1696, 2006

Matrix Metalloproteinases in Myocardial Infarction and Heart Failure. Progress in Molecular Biology and Translational Science 147: 75-100, 2017

Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats. Journal of the American College of Cardiology 39(8): 1384-1391, April 17, 2002

Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium. Annals of Medicine 33(9): 623-634, 2002

Excess of Matrix Metalloproteinases over their tissue inhibitors contributes to left ventricular structural remodeling during transition from hypertrophy to heart failure in hypertensive rats. Circulation 100(18 SUPPL ): I 565, Nov 2, 1999

Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 113(17): 2089-2096, 2006

Myocardial collagen matrix remodeling and congestive heart failure. Cardiologia 39(12 Suppl 1): 389-393, 1994

Myocardial extracellular matrix remodeling in ischemic heart failure. Frontiers in Bioscience 12: 1410-1419, 2007

Myocardial extracellular matrix remodeling in ischemic heart failure. Frontiers in Bioscience 12: 1410-1419, 2006

Controlling myocardial matrix remodeling: implications for heart failure. Cardiology in Review 7(3): 136-143, 1999

Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiological Reviews 87(4): 1285-1342, 2007

Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor. Circulation 109(17): 2143-2149, 2004